174 related articles for article (PubMed ID: 36016484)
1. Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation.
Zhang NN; Zheng J; Wu Y; Lv JY; Zhang SW; Zhang YM; Jiang WT; Song TQ; Kim V; Tohme S; Liu T; Zhang W; Gu J; Wang ZY; Suo YH; Wang S; Li W; Zhang L; Xie Y; Zhou YH; Liu JY; Qiu YB; Shen ZY; Hao JH; Geller D; Lu W
Cancer Med; 2023 Feb; 12(3):2312-2324. PubMed ID: 36016484
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source.
Sung PS; Yang H; Na GH; Hwang S; Kang D; Jang JW; Bae SH; Choi JY; Kim DG; Yoon SK; You YK
Ann Transplant; 2017 May; 22():276-284. PubMed ID: 28473688
[TBL] [Abstract][Full Text] [Related]
4. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
Lei JY; Yan LN; Wang WT
World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
Lee KK; Kim DG; Moon IS; Lee MD; Park JH
J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
[TBL] [Abstract][Full Text] [Related]
8. Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Pelizzaro F; Trevisani F; Simeon V; Vitale A; Cillo U; Piscaglia F; Missale G; Sangiovanni A; Foschi FG; Cabibbo G; Caturelli E; Di Marco M; Azzaroli F; Brunetto MR; Raimondo G; Vidili G; Guarino M; Gasbarrini A; Campani C; Svegliati-Baroni G; Giannini EG; Mega A; Masotto A; Rapaccini GL; Magalotti D; Sacco R; Nardone G; Farinati F;
Liver Int; 2023 Dec; 43(12):2762-2775. PubMed ID: 37753540
[TBL] [Abstract][Full Text] [Related]
9. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
[TBL] [Abstract][Full Text] [Related]
10. Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.
Muaddi H; Al-Adra DP; Beecroft R; Ghanekar A; Moulton CA; Doyle A; Selzner M; Wei A; McGilvray ID; Gallinger S; Grant DR; Cattral MS; Greig PD; Kachura J; Cleary SP; Sapisochin G
Ann Surg Oncol; 2018 Apr; 25(4):991-999. PubMed ID: 29327179
[TBL] [Abstract][Full Text] [Related]
11. Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.
Menahem B; Duvoux C; Ganne N; Mallat A; Seror O; Calderaro J; Launoy G; Alves A; Cherqui D; Luciani A; Laurent A
World J Surg; 2019 Jan; 43(1):221-229. PubMed ID: 30128773
[TBL] [Abstract][Full Text] [Related]
12. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
Huang J; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):406-9. PubMed ID: 24670459
[TBL] [Abstract][Full Text] [Related]
13. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
15. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
[TBL] [Abstract][Full Text] [Related]
16. Predictive effects of a combined indicator in patients with hepatocellular carcinoma after thermal ablation.
Yang Q; Yu XL; Wang Y; Cheng ZG; Han ZY; Liu FY; Qian TG; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1038-1050. PubMed ID: 33004745
[TBL] [Abstract][Full Text] [Related]
17. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
[TBL] [Abstract][Full Text] [Related]
18. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
[TBL] [Abstract][Full Text] [Related]
19. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
